Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

[1]  P. Piccini,et al.  Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases , 2016, Neuropathology and applied neurobiology.

[2]  John Q. Trojanowski,et al.  Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease , 2016, Alzheimer's & Dementia.

[3]  M. Albert,et al.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[4]  J. Trojanowski,et al.  Longitudinal study of normal cognition in Parkinson disease , 2015, Neurology.

[5]  T. Hortobágyi,et al.  Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias , 2014, Brain pathology.

[6]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[7]  Arthur W Toga,et al.  Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. , 2013, JAMA neurology.

[8]  J. Trojanowski,et al.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.

[9]  Bin Zhang,et al.  Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.

[10]  Daniel Weintraub,et al.  APOE ε4 increases risk for dementia in pure synucleinopathies. , 2013, JAMA neurology.

[11]  Janna H. Neltner,et al.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology , 2012, Neurology.

[12]  John L. Robinson,et al.  Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.

[13]  Eden R Martin,et al.  Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2 , 2012, Annals of neurology.

[14]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[15]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[16]  Constantinos Kallis,et al.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.

[17]  T Revesz,et al.  A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.

[18]  Dag Aarsland,et al.  Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology , 2009, Alzheimer disease and associated disorders.

[19]  G. Halliday,et al.  The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.

[20]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  E. Perry,et al.  Differences in neuropathologic characteristics across the Lewy body dementia spectrum , 2006, Neurology.

[22]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[23]  J. Trojanowski,et al.  More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases , 2004, Trends in Neurosciences.

[24]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[25]  K. Jellinger,et al.  Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.

[26]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[27]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[28]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[29]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .